"10.1371_journal.pone.0153088","plos one","2016-04-06T00:00:00Z","Hampartsoum B Barsoumian; Esma S Yolcu; Haval Shirwan","Institute for Cellular Therapeutics and Department of Microbiology and Immunology, University of Louisville, Louisville, Kentucky, 40202, United States of America","Conceived and designed the experiments: HB EY HS. Performed the experiments: HB. Analyzed the data: HB EY HS. Wrote the paper: HB EY HS.","The authors of this manuscript have read the journal's policy and authors Haval Shirwan and Esma S. Yolcu serve as inventors on SA-4-1BBL composition and use patents. Haval Shirwan is the founder of FasCure Therapeutics, LLC, that has exclusive rights on SA-4-1BBL use for immunotherapy. The other authors have no additional conflicts of interests. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2016","04","Hampartsoum B Barsoumian","HBB",3,TRUE,3,1,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
